CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Entest Group Inc   (ENTB)
Other Ticker:  
 

Cumulative Entest Group Inc 's Working Capital Ratio for Trailing Twelve Months Period

ENTB's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ENTB Working Capital Ratio for Trailing Twelve Months Period

 (Nov 30 2019)
I. Quarter		 (Aug 31 2019)
IV. Quarter		 (May 31 2019)
III. Quarter		 (Feb 28 2019)
II. Quarter		 (Nov 30 2018)
I. Quarter
Y / Y Current Liabilities Growth 821.82 % -85.78 % -95.65 % -93.74 % -97.98 %
Y / Y Current Assets Growth - - -99.83 % -99.9 % -99.89 %
Working Capital Ratio for Trailing Twelve Months Period 0.02 0.04 0.05 0.72 1.45
Total Ranking # # # # #
Seq. Current Liabilities Growth 55.05 % 21.56 % 65.03 % 196.36 % -97.61 %
Seq. Current Assets Growth - - 0 % -12.53 % -87.22 %

ENTB Segments >> Back to ENTB Financial Strength Comparisons >> Compare ENTB Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Nov 30 2019
On the trailing twelve months basis Due to unchange in Current Liabilities in the I. Quarter to $0 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.02 above Entest Group Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry Entest Group Inc achieved highest Working Capital Ratio for Trailing Twelve Months Period. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about ENTB
Working Capital Ratio ENTB in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Nov 30 2019, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Iaso Biomed, Inc.  0.04 
Rapid Therapeutic Science Laboratories Inc   0.03 
Propanc Biopharma Inc   0.03 
Allarity Therapeutics Inc   0.03 
Bioadaptives Inc   0.02 
Entest Group Inc   0.02 
Rebus Holdings Inc   0.02 
Optec International, Inc.  0.02 
Theralink Technologies Inc   0.02 
Abvc Biopharma Inc   0.02 
Xynomic Pharmaceuticals Holdings Inc   0.02 
Respirerx Pharmaceuticals Inc   0.02 
Cell Source Inc   0.01 
Kaya Holdings Inc  0.01 
Gt Biopharma Inc  0.01 
Regen Biopharma Inc  0.01 
Skinvisible Inc   0.01 
Biostax Corp 0.00 
Hst Global Inc 0.00 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com